What one share of Champions Oncology holds
We are a technology-enabled research organization engaged in creating technology solutions to be utilized in drug discovery and development. Our research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms.
Champions Oncology’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-31; the balance sheet is as of 2026-07-31.
| Sales | $4.38 |
|---|---|
| Profit | −$0.08 |
| Capex (buildings and equipment) | $0.04 |
| Free cash flow | −$0.44 |
| Cash and investments | $0.31 |
| Book value | $0.28 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | — | −$1.32 | $0.03 | −$0.05 | — | — |
| 2012 | — | −$2.22 | $0.13 | −$1.47 | — | — |
| 2013 | — | −$1.46 | $0.01 | −$1.00 | — | — |
| 2014 | — | −$1.33 | $0.04 | −$0.66 | — | — |
| 2015 | — | −$2.20 | $0.02 | −$1.52 | — | — |
| 2016 | — | −$1.20 | $0.04 | −$0.77 | — | — |
| 2017 | — | −$0.64 | $0.07 | −$0.34 | — | — |
| 2018 | $1.84 | −$0.13 | $0.11 | −$0.22 | — | — |
| 2019 | $1.92 | $0.01 | $0.06 | $0.07 | — | $0.18 |
| 2020 | $2.71 | −$0.18 | $0.19 | $0.06 | — | $0.40 |
| 2021 | $2.82 | $0.02 | $0.23 | −$0.34 | — | $0.55 |
| 2022 | $3.47 | $0.04 | $0.17 | $0.29 | — | $0.67 |
| 2023 | $3.98 | −$0.39 | $0.21 | $0.08 | — | $0.34 |
| 2024 | $3.70 | −$0.54 | $0.06 | −$0.51 | — | −$0.14 |
| 2025 | $3.99 | $0.33 | $0.03 | $0.49 | — | $0.27 |
| 2026 | $4.30 | −$0.08 | $0.04 | −$0.36 | — | $0.28 |
Common questions about Champions Oncology
How much does one share of Champions Oncology earn?
Over the last 12 months, Champions Oncology lost $0.08 for each share on $4.38 of sales.
Does Champions Oncology pay a dividend?
Champions Oncology didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Champions Oncology’s book value per share?
Champions Oncology’s book value is $0.28 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of July 31, 2026.
How much cash and debt does each share of Champions Oncology have?
Each share of Champions Oncology has $0.31 of cash and investments, as of July 31, 2026.
What is Champions Oncology’s free cash flow per share?
−$0.44 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Champions Oncology bought back shares?
Champions Oncology’s share count rose about 380% from 2011 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.